» Articles » PMID: 25186948

Serine Catabolism Regulates Mitochondrial Redox Control During Hypoxia

Overview
Journal Cancer Discov
Specialty Oncology
Date 2014 Sep 5
PMID 25186948
Citations 257
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: The de novo synthesis of the nonessential amino acid serine is often upregulated in cancer. In this study, we demonstrate that the serine catabolic enzyme, mitochondrial serine hydroxymethyltransferase (SHMT2), is induced when MYC-transformed cells are subjected to hypoxia. In mitochondria, SHMT2 can initiate the degradation of serine to CO2 and NH4+, resulting in net production of NADPH from NADP+. Knockdown of SHMT2 in MYC-dependent cells reduced cellular NADPH:NADP+ ratio, increased cellular reactive oxygen species, and triggered hypoxia-induced cell death. In vivo, SHMT2 suppression led to impaired tumor growth. In MYC-amplified neuroblastoma patient samples, there was a significant correlation between SHMT2 and hypoxia-inducible factor-1 α (HIF1α), and SHMT2 expression correlated with unfavorable patient prognosis. Together, these data demonstrate that mitochondrial serine catabolism supports tumor growth by maintaining mitochondrial redox balance and cell survival.

Significance: In this study, we demonstrate that the mitochondrial enzyme SHMT2 is induced upon hypoxic stress and is critical for maintaining NADPH production and redox balance to support tumor cell survival and growth.

Citing Articles

NINJ1 in Cell Death and Ferroptosis: Implications for Tumor Invasion and Metastasis.

Chen S, Shyu I, Chi J Cancers (Basel). 2025; 17(5).

PMID: 40075648 PMC: 11898531. DOI: 10.3390/cancers17050800.


Cancer-intrinsic Cxcl5 orchestrates a global metabolic reprogramming for resistance to oxidative cell death in 3D.

Seo R, de Guzman A, Park S, Lee J, Kang S Cell Death Differ. 2025; .

PMID: 40050422 DOI: 10.1038/s41418-025-01466-y.


The Two Faces of Reactive Oxygen Species in Cancer.

Reczek C, Chandel N Annu Rev Cancer Biol. 2025; 1:79-98.

PMID: 40034143 PMC: 11875389. DOI: 10.1146/annurev-cancerbio-041916-065808.


MAPK13 phosphorylates PHGDH and promotes its degradation via chaperone-mediated autophagy during liver injury.

Xing R, Liu R, Man Y, Liu C, Zhang Y, Gao H Cell Discov. 2025; 11(1):15.

PMID: 39962071 PMC: 11832932. DOI: 10.1038/s41421-024-00758-w.


Hypoxia-induced one-carbon metabolic reprogramming in glioma stem-like cells.

He X, Wang J, Shi M, Liu C, Teng Z Life Med. 2025; 2(6):lnad048.

PMID: 39872059 PMC: 11749232. DOI: 10.1093/lifemedi/lnad048.


References
1.
Semenza G . Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta. 2010; 1813(7):1263-8. PMC: 3010308. DOI: 10.1016/j.bbamcr.2010.08.006. View

2.
Lemons J, Feng X, Bennett B, Legesse-Miller A, Johnson E, Raitman I . Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol. 2010; 8(10):e1000514. PMC: 2958657. DOI: 10.1371/journal.pbio.1000514. View

3.
Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P . Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996; 56(19):4509-15. View

4.
Rhodes D, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs B . Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007; 9(2):166-80. PMC: 1813932. DOI: 10.1593/neo.07112. View

5.
Guzy R, Hoyos B, Robin E, Chen H, Liu L, Mansfield K . Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005; 1(6):401-8. DOI: 10.1016/j.cmet.2005.05.001. View